Debra Italia
Debra Italia onlus is the Italian association focused on epidermolysis bullosa (EB). Debra has been operating in Italy since the early nineties promoting social and health care ac-tivities, raising awareness within the patients’ community and fostering research on EB. Epidermolysis bullosa, also known as the diseases of “butterfly kids”, is a severe rare ge-netic disease causing the skin and mucous membranes to be very fragile. Blisters and areas of skin loss -which can be quite large- occur since birth as a result of minor injuries or friction. In Italy, EB affects 1 in 82000 children; there is currently no cure for this disease.
Science Compass, Debra Italia onlus, ricerca sull’epidermolisi bollosa, ricerca scientifica, sostenere lo sviluppo terapeutico, bambini farfalla, malattia genetica,
17751
post-template-default,single,single-post,postid-17751,single-format-standard,bridge-core-1.0.6,cookies-not-set,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,side_area_uncovered_from_content,vss_responsive_adv,vss_width_768,qode-theme-ver-18.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Debra Italia

Debra Italia

Advancing research for butterfly kids

debra Italia Onlus

Debra Italia onlus is the Italian association focused on epidermolysis bullosa (EB). Debra has been operating in Italy since the early nineties promoting social and health care activities, raising awareness within the patients’ community and fostering research on EB.

Epidermolysis bullosa, also known as the diseases of “butterfly kids”, is a severe rare genetic disease causing the skin and mucous membranes to be very fragile. Blisters and areas of skin loss -which can be quite large- occur since birth as a result of minor injuries or friction.

In Italy, EB affects 1 in 82000 children; there is currently no cure for this disease.

Science Compass is assisting Debra Italia along the plan to trigger research on EB; the ultimate goal is to identify novel approaches for therapy development and disease man-agement.

Among the first actions taken within this strategic framework was the activation of a disease registry to foster sharing and collaboration within the patients’ and scientific communities.

No Comments

Post A Comment

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.